Small cell lung cancer remains a major unmet medical need.
New cancer cell treatment.
It genetically reprograms the t cell to seek out and recognise and destroy the patient s tumour cells.
Lurbinectedin is the first new drug approved for second line treatment since 1996.
Doctors first remove t cells from your blood.
Then they change genes in the cells to help them find and destroy.
Excitement at new cancer treatment.
By james gallagher health editor bbc news website.
To treat cancer doctors have employed surgery chemotherapy and radiation therapy for years but adoptive cell transfer is an immunotherapy treatment that has rapidly emerged in recent years.
Charles rudin chief of the thoracic oncology service.
Many of us in the oncology community will welcome lurbinectedin as a new standard option for patients with recurrent small cell lung cancer said dr.
Kte x19 car t cell therapy in relapsed or refractory mantle cell lymphoma new england journal of medicine 2020.